Press "Enter" to skip to content

Shire sells cancer drugs to Servier for $2.4 billion as Takeda circles

LONDON (Reuters) – Shire, the London-listed rare diseases specialist that is a potential takeover target for Japan’s Takeda Pharmaceutical, is selling its oncology business to unlisted French drugmaker Servier for $2.4 billion.


Source: Health

Be First to Comment

Leave a Reply